Predicting Esophageal Cancer Borders Using PET-Imaging
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital Heidelberg
About this trial
The study examines the diagnostic precision of endosonography, mpMRI and PET/CT in defining tumor boundaries and tumor spread before and after neoadjuvant therapy and definitive surgery.
Eligibility criteria
Qualifiers
Histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus, including AEG I and AEG II tumors in the primary situation
Planned surgical treatment of esophageal carcinoma
Possible staging advantage through FAPI PET/CT diagnostics
Patient information and written consent
Disqualifiers
Previous radiation therapy in the tumor region
Previous tumor disease with < 5 years of remission
Surgical therapy is not functionally or technically possible
Distant metastasis
Trial design
Treatments tested in this trial
- photon
- surgical therapy
- Chemotherapy
Treatment groups
30 Participants
are divided into 3 treatment groupsLocations
1Department of Radiotherapy, University of Heidelberg69120, Heidelberg Germany
Sponsors and collaborators
University Hospital Heidelberg
Lead sponsor
Source ClinicalTrials.gov